Value of magnetic resonance angiography before prostatic artery embolization for intervention planning.

Benign prostatic hyperplasia MR angiography Prostate MRI Prostatic artery embolization

Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
02 Apr 2024
Historique:
received: 28 04 2023
accepted: 26 03 2024
medline: 3 4 2024
pubmed: 3 4 2024
entrez: 2 4 2024
Statut: epublish

Résumé

Knowledge about anatomical details seems to facilitate the procedure and planning of prostatic artery embolization (PAE) in patients with symptomatic benign prostatic hyperplasia (BPS). The aim of our study was the pre-interventional visualization of the prostatic artery (PA) with MRA and the correlation of iliac elongation and bifurcation angles with technical success of PAE and technical parameters. MRA data of patients with PAE were analysed retrospectively regarding PA visibility, PA type, vessel elongation, and defined angles were correlated with intervention time, fluoroscopy time, dose area product (DAP), cumulative air kerma (CAK), contrast media (CM) dose and technical success of embolization. T-test, ANOVA, Pearson correlation, and Kruskal-Wallis test was applied for statistical analysis. Between April 2018 and March 2021, a total of 78 patients were included. MRA identified the PA origin in 126 of 147 cases (accuracy 86%). Vessel elongation affected time for catheterization of right PA (p = 0.02), fluoroscopy time (p = 0.05), and CM dose (p = 0.02) significantly. Moderate correlation was observed for iliac bifurcation angles with DAP (r = 0.30 left; r = 0.34 right; p = 0.01) and CAK (r = 0.32 left; r = 0.36 right; p = 0.01) on both sides. Comparing the first half and second half of patients, median intervention time (125 vs. 105 min.) and number of iliac CBCT could be reduced (p < 0.001). We conclude that MRA could depict exact pelvic artery configuration, identify PA origin, and might obviate iliac CBCT. Vessel elongation of pelvic arteries increased intervention time and contrast media dose while the PA origin had no significant influence on intervention time and/or technical success.

Identifiants

DOI: 10.1038/s41598-024-58207-3 PMID: 38565890
pubmed: 38565890
doi: 10.1038/s41598-024-58207-3
pii: 10.1038/s41598-024-58207-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7758

Informations de copyright

© 2024. The Author(s).

Références

Teichgräber, U. et al. Prostate artery embolization: Indication, technique and clinical results. RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 190, 847–855 (2018).
doi: 10.1055/a-0612-8067 pubmed: 29975976
Wang, M. Q. et al. Benign prostatic hyperplasia: Cone-beam CT in conjunction with DSA for identifying prostatic arterial anatomy. Radiology 282, 271–280 (2017).
doi: 10.1148/radiol.2016152415 pubmed: 27467466
Christidis, D. et al. Prostatic artery embolization for benign prostatic obstruction: Assessment of safety and efficacy. World J. Urol. 36, 575–584 (2018).
doi: 10.1007/s00345-018-2220-z pubmed: 29445846
Abt, D., Schmid, H.-P. & Speakman, M. J. Reasons to consider prostatic artery embolization. World J. Urol. 39, 2301–2306 (2021).
doi: 10.1007/s00345-021-03601-z pubmed: 33569641
Insausti, I. et al. Randomized comparison of prostatic artery embolization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia. J. Vasc. Intervent. Radiol. JVIR 31, 882–890 (2020).
doi: 10.1016/j.jvir.2019.12.810
Abt, D. et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: Randomised, open label, non-inferiority trial. BMJ (Clinical research ed.) 361, k2338 (2018).
Kovács, A. et al. Positionspapier der Deutschen Gesellschaft für Interventionsradiologie (DeGIR) zur Prostataarterienembolisation. RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 192, 835–846 (2020).
pubmed: 32615637
Zumstein, V. et al. Prostatic artery embolization versus standard surgical treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A systematic review and meta-analysis. Eur. Urol. Focus 5, 1091–1100 (2019).
doi: 10.1016/j.euf.2018.09.005 pubmed: 30292422
Carnevale, F. C. et al. Anatomical variants in prostate artery embolization: A pictorial essay. Cardiovasc. Intervent. Radiol. 40, 1321–1337 (2017).
doi: 10.1007/s00270-017-1687-0 pubmed: 28508252
Maclean, D. et al. Planning prostate artery embolisation: Is it essential to perform a pre-procedural CTA?. Cardiovasc. Intervent. Radiol. 41, 628–632 (2018).
doi: 10.1007/s00270-017-1842-7 pubmed: 29167966
Kovács, A. Prostate artery embolization (PAE): Technique and results. Der Radiologe 57, 641–651 (2017).
doi: 10.1007/s00117-017-0248-5 pubmed: 28455657
Enderlein, G. F. et al. Prostatic artery embolization-anatomic predictors of technical outcomes. J. Vasc. Intervent. Radiol. JVIR 31, 378–387 (2020).
doi: 10.1016/j.jvir.2019.09.005
Lintin, L., Barge, T., Boardman, P., Tong, G. & Tapping, C. Predictors of technical outcome for prostatic artery embolisation using pre-procedural CT angiography. Eur. Radiol. 31, 1308–1315 (2021).
doi: 10.1007/s00330-020-07244-3 pubmed: 32909056
Du Pisanie, J. et al. Predictors of prostatic artery embolization technical outcomes: Patient and procedural factors. J. Vasc. Intervent. Radiol. JVIR 30, 233–240 (2019).
doi: 10.1016/j.jvir.2018.09.014
Chiaradia, M. et al. Automatic three-dimensional detection of prostatic arteries using cone-beam CT during prostatic arterial embolization. J. Vasc. Intervent. Radiol. JVIR 26, 413–417 (2015).
doi: 10.1016/j.jvir.2014.11.009
Kim, A. Y., Field, D. H., DeMulder, D., Spies, J. & Krishnan, P. Utility of MR angiography in the identification of prostatic artery origin prior to prostatic artery embolization. J. Vasc. Intervent. Radiol. JVIR 29, 307-310.e1 (2018).
doi: 10.1016/j.jvir.2017.11.001
Zhang, J. L. et al. Effectiveness of contrast-enhanced MR angiography for visualization of the prostatic artery prior to prostatic arterial embolization. Radiology 291, 370–378 (2019).
doi: 10.1148/radiol.2019181524 pubmed: 30806596
Franiel, T. et al. mpMRI of the prostate (MR-prostatography): Updated recommendations of the DRG and BDR on patient preparation and scanning protocol. RoFo Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 193, 763–777 (2021).
pubmed: 33735931
Boschheidgen, M. et al. Influence of benign prostatic hyperplasia patterns detected with MRI on the clinical outcome after prostatic artery embolization. CVIR Endovasc. 6, 9 (2023).
doi: 10.1186/s42155-023-00357-y pubmed: 36859572 pmcid: 9978045
Dias, U. S. Jr. et al. Prostatic artery embolization: Indications, preparation, techniques, imaging evaluation, reporting, and complications. RadioGraphics 41, 1509–1530 (2021).
doi: 10.1148/rg.2021200144 pubmed: 34415807
Hacking, N. et al. Technical and imaging outcomes from the UK Registry of Prostate Artery Embolization (UK-ROPE) Study: Focusing on predictors of clinical success. Cardiovasc. Intervent. Radiol. 42, 666–676 (2019).
doi: 10.1007/s00270-018-02156-8 pubmed: 30603967
Bilhim, T., Tinto, H. R., Fernandes, L. & Martins Pisco, J. Radiological anatomy of prostatic arteries. Tech. Vasc. Intervent. Radiol. 15, 276–285 (2012).
doi: 10.1053/j.tvir.2012.09.006
Cohen, J. Statistical Power Analysis for the Behavioral Sciences (Lawrence Erlbaum Associates, 1988).
Schimmöller, L. et al. Predictive power of the ESUR scoring system for prostate cancer diagnosis verified with targeted MR-guided in-bore biopsy. Eur. J. Radiol. 83, 2103–2108 (2014).
doi: 10.1016/j.ejrad.2014.08.006 pubmed: 25241051
Schimmöller, L. et al. MR-sequences for prostate cancer diagnostics: Validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy. Eur. Radiol. 24, 2582–2589 (2014).
doi: 10.1007/s00330-014-3276-9 pubmed: 24972954
Malling, B. et al. Prostate artery embolisation for benign prostatic hyperplasia: A systematic review and meta-analysis. Eur. Radiol. 29, 287–298 (2019).
doi: 10.1007/s00330-018-5564-2 pubmed: 29948079
Vogl, T. J. et al. MR angiography-planned prostatic artery embolization for benign prostatic hyperplasia: Single-center retrospective study in 56 patients. Diagnostic Intervent. Radiol. (Ankara, Turkey) 27, 725–731 (2021).
doi: 10.5152/dir.2021.20124
McWilliams, J. P. et al. Society of Interventional Radiology Multisociety Consensus Position Statement on Prostatic Artery Embolization for Treatment of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: From the Society of Interventional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, Société Française de Radiologie, and the British Society of Interventional Radiology: Endorsed by the Asia Pacific Society of Cardiovascular and Interventional Radiology, Canadian Association for Interventional Radiology, Chinese College of Interventionalists, Interventional Radiology Society of Australasia, Japanese Society of Interventional Radiology, and Korean Society of Interventional Radiology. J. Vasc. Intervent. Radiol. JVIR 30, 627-637.e1 (2019).
doi: 10.1016/j.jvir.2019.02.013
Bürckenmeyer, F. et al. Prostatic artery embolization: Influence of cone-beam computed tomography on radiation exposure, procedure time, and contrast media use. Cardiovasc. Intervent. Radiol. 44, 1089–1094 (2021).
doi: 10.1007/s00270-021-02787-4 pubmed: 33660064 pmcid: 8190013
Schott, P., Katoh, M., Fischer, N. & Freyhardt, P. Radiation dose in prostatic artery embolization using cone-beam CT and 3D roadmap software. J. Vasc. Intervent. Radiol. JVIR 30, 1452–1458 (2019).
doi: 10.1016/j.jvir.2019.04.040
Kriechenbauer, B. M. T. et al. Influence of interventionists’ experience on radiation exposure of patients who underwent prostate artery embolization: 4-year results from a retrospective. Single-center study. Cardiovasc. Intervent. Radiol. 43, 1194–1201 (2020).
doi: 10.1007/s00270-020-02461-1 pubmed: 32342165 pmcid: 7369265

Auteurs

Matthias Boschheidgen (M)

Department of Diagnostic and Interventional Radiology, University Dusseldorf, Medical Faculty, Moorenstr. 5, 40225, Dusseldorf, Germany.

Tim Ullrich (T)

Department of Diagnostic and Interventional Radiology, University Dusseldorf, Medical Faculty, Moorenstr. 5, 40225, Dusseldorf, Germany.

Rouvier Al-Monajjed (R)

Department of Urology, University Dusseldorf, Medical Faculty, Moorenstr. 5, 40225, Dusseldorf, Germany.

Farid Ziayee (F)

Department of Diagnostic and Interventional Radiology, University Dusseldorf, Medical Faculty, Moorenstr. 5, 40225, Dusseldorf, Germany.

Rene Michalski (R)

Department of Urology, University Dusseldorf, Medical Faculty, Moorenstr. 5, 40225, Dusseldorf, Germany.

Andrea Steuwe (A)

Department of Diagnostic and Interventional Radiology, University Dusseldorf, Medical Faculty, Moorenstr. 5, 40225, Dusseldorf, Germany.

Peter Minko (P)

Department of Diagnostic and Interventional Radiology, University Dusseldorf, Medical Faculty, Moorenstr. 5, 40225, Dusseldorf, Germany.

Peter Albers (P)

Department of Urology, University Dusseldorf, Medical Faculty, Moorenstr. 5, 40225, Dusseldorf, Germany.

Gerald Antoch (G)

Department of Diagnostic and Interventional Radiology, University Dusseldorf, Medical Faculty, Moorenstr. 5, 40225, Dusseldorf, Germany.

Lars Schimmöller (L)

Department of Diagnostic and Interventional Radiology, University Dusseldorf, Medical Faculty, Moorenstr. 5, 40225, Dusseldorf, Germany. Lars.Schimmoeller@med.uni-duesseldorf.de.
Department of Diagnostic, Interventional Radiology and Nuclear Medicine, Marien Hospital Herne, University Hospital of the Ruhr-University Bochum, Herne, Germany. Lars.Schimmoeller@med.uni-duesseldorf.de.
ORCID: 0000-0001-7476-292X

Classifications MeSH